Pfizer Inc. PFE

28.67 0.26 0.92% as of 25 Sep
Market cap
$161.7B
P/E
37.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
18.31 18.70 82.58 9.20 15.14 21.40 12.77 22.03 9.68 26.76
P/S ratio
2.26 2.36 2.82 2.84 4.07 4.91 5.06 5.96 3.93 3.61
P/FCF ratio
17.10 16.63 42.00 11.39 11.38 17.97 20.45 17.76 14.23 13.48
P/Operating CF
26.46 22.36 32.02 33.50 55.92 36.35 54.92 51.32 29.11 31.56
P/B ratio
1.63 1.70 1.88 3.00 4.27 3.22 3.26 3.81 2.88 3.19
Price to Tangible BV
0.00 0.00 0.00 245.28 106.42 0.00 0.00 0.00 0.00 0.00
EV/Sales
3.08 3.05 3.81 2.97 4.16 5.57 6.10 6.52 4.37 4.07
EV/EBITDA
9.25 9.99 29.99 7.36 13.73 17.95 20.02 22.51 11.50 12.00
EV/Operating CF
16.46 15.23 26.09 10.27 10.38 16.11 19.82 16.81 13.68 13.27
EV/FCF
23.28 21.49 56.83 11.91 11.63 20.40 24.64 19.43 15.85 15.19
Quick Ratio
0.69 0.74 0.51 0.80 1.00 0.78 0.44 0.84 0.93 0.84
Current Ratio
1.16 1.17 0.91 1.22 1.40 1.35 0.88 1.57 1.35 1.25
Net Debt/EBITDA
2.46 2.26 7.82 0.32 0.30 2.14 3.41 1.94 1.18 1.35
Debt/Assets
31.13% 30.16% 31.74% 18.17% 21.18% 25.83% 31.12% 26.18% 25.32% 24.52%
Debt/Equity
0.75 0.73 0.81 0.37 0.50 0.63 0.82 0.65 0.61 0.70
Asset Turnover
0.30 0.29 0.28 0.53 0.48 0.26 0.25 0.25 0.31 0.31
Operating CF/Net income
1.51 1.59 4.11 0.93 1.48 1.57 0.79 1.42 0.79 2.24
Capex/Depreciation
(0.40) (0.41) (0.62) (0.64) (0.52) (0.59) (0.43) (0.35) (0.35) (0.35)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
8.87% 9.03% 2.29% 36.19% 31.19% 14.43% 25.20% 16.48% 32.42% 11.56%
ROA
3.69% 3.65% 1.00% 16.57% 13.09% 5.69% 9.80% 6.73% 12.41% 4.26%
ROIC
6.45% 5.86% 0.54% 20.52% 14.32% 5.66% 3.96% 4.09% 9.01% 9.03%
Return on Tangible Assets
30.80% 31.18% 14.63% 123.54% 68.89% 40.01% 189.25% 35.46% 86.69% 34.11%
Average Days of Receivables
69.26 65.76 70.89 39.51 51.54 69.34 60.43 71.75 57.11 56.83
Research and Development Expense of Revenue
16.68% 17.01% 17.93% 11.30% 12.74% 20.91% 20.50% 19.01% 14.62% 14.94%
Selling, General and Administrative Expense of Revenue
22.04% 23.15% 24.80% 13.52% 15.63% 27.84% 31.11% 30.89% 28.17% 28.10%
Intangible Assets out of Total Assets
0.60 0.58 0.59 0.48 0.41 0.51 0.49 0.56 0.61 0.62
Share Based Compensation of Revenue
1.28% 1.38% 0.88% 0.86% 1.45% 1.81% 1.68% 2.26% 1.60% 1.31%
Graham Net Nets
(0.55) (0.50) (0.56) (0.17) (0.13) (0.27) (0.34) (0.19) (0.29) (0.38)
Graham Number
21.62 22.33 11.32 46.30 34.84 21.03 27.31 21.43 31.05 16.08
Earnings Yield
5.46% 5.35% 1.21% 10.87% 6.60% 4.67% 7.83% 4.54% 10.33% 3.74%
Free Cash Flow Yield
5.85% 6.01% 2.38% 8.78% 8.79% 5.56% 4.89% 5.63% 7.03% 7.42%
Revenue per Share
11.01 11.23 10.55 18.04 14.51 7.50 7.35 6.95 8.80 8.68
Operating CF per Share
2.06 2.25 1.54 5.22 5.82 2.59 2.26 2.70 2.81 2.66
Capex per Share
(0.46) (0.51) (0.69) (0.58) (0.48) (0.50) (0.44) (0.36) (0.37) (0.33)
Free Cash Flow per Share
1.60 1.74 0.85 4.64 5.33 2.10 1.82 2.33 2.44 2.33
Cash per Share
2.39 3.62 2.25 4.05 5.55 2.20 1.73 3.21 3.35 2.93
Shareholders Equity per Share
15.27 15.62 15.82 17.10 13.83 11.43 11.39 10.86 12.00 9.83
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
15.27 15.62 15.82 17.10 13.83 11.43 11.39 10.86 12.00 9.83
Free Cash Flow
9,075.00 9,835.00 4,793.00 26,031.00 29,869.00 11,638.00 10,124.00 13,691.00 14,585.00 14,193.00
Working Capital
5,914.00 7,363.00 (4,461.00) 9,121.00 17,022.00 9,147.00 (4,501.00) 18,068.00 10,714.00 7,834.00
Capital Expenditures
(2,629.00) (2,909.00) (3,907.00) (3,236.00) (2,711.00) (2,765.00) (2,464.00) (2,136.00) (2,217.00) (1,999.00)
Net Current Asset Value
(78,487.00) (74,541.00) (93,880.00) (50,029.00) (44,320.00) (55,689.00) (71,345.00) (45,738.00) (59,000.00) (72,827.00)
EV/EBIT
13.53 15.64 177.45 8.40 17.40 28.13 37.18 46.91 16.75 17.69
Capex to Sales
0.04 0.05 0.07 0.03 0.03 0.07 0.06 0.05 0.04 0.04
Net Profit Margin
12.42% 12.62% 3.56% 31.01% 27.04% 21.99% 39.18% 27.32% 40.55% 13.66%
Price to Operating Income
9.93 12.11 131.17 8.03 17.02 24.79 30.85 42.87 15.04 15.70
Other line items
Depreciation/Fixed assets
0.34 0.38 0.33 0.31 0.35 0.34 0.44 0.46 0.45 0.43
Cash ROIC
(4.61%) (3.26%) (5.89%) 8.41% 12.04% 0.57% (0.30%) 1.96% 2.17% 2.40%
Accounts Receivable Turnover
5.36 5.53 5.29 9.02 8.38 5.67 5.53 5.03 6.39 6.44
Accounts Payable Turnover
2.96 2.89 3.69 5.55 6.25 2.08 1.88 1.93 2.44 3.02
Inventory Turnover
1.49 1.70 2.60 3.81 3.61 1.12 1.11 1.19 1.56 1.72
Average Days of Payables
119.04 115.18 98.15 72.36 66.06 184.26 176.16 189.83 151.36 134.36
Days of Inventory on Hand
242.03 221.87 149.03 95.45 107.28 345.04 320.32 304.93 246.35 200.92
Average Receivables
11,668.50 11,514.50 11,259.00 11,215.50 9,696.00 7,342.50 7,398.50 8,123.00 8,223.00 8,200.50
Average Payables
5,436.50 6,171.50 6,759.50 6,193.50 4,930.50 4,085.00 4,280.50 4,665.00 4,596.00 4,078.00
Average Inventory
10,752.50 10,520.00 9,585.00 9,020.00 8,539.50 7,544.00 7,288.00 7,543.00 7,180.50 7,148.00
Average Assets
210,778.00 219,948.50 211,853.00 189,340.50 167,852.50 160,911.50 163,508.00 165,609.50 171,706.00 169,498.00
Average Common Equity
87,636.00 88,892.50 92,602.50 86,689.50 70,467.50 63,450.50 63,584.00 67,687.50 65,725.50 62,394.00

Fold the line items

Columns are period end dates